Cica-Huntek Chemical Technology Taiwan Co

As of June 30, 2026, Cica-Huntek Chemical Technology Taiwan Co carries a market capitalization of 12.96B, placing it among publicly traded companies globally. Its enterprise value stands at 12.55B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Cica-Huntek Chemical Technology Taiwan Co's next confirmed earnings release is scheduled for November 12, 2026.

As of June 30, 2026, Cica-Huntek Chemical Technology Taiwan Co has 37.13M shares outstanding.

As of June 30, 2026, Cica-Huntek Chemical Technology Taiwan Co trades at a trailing price-to-earnings ratio of 71.95. The price-to-sales ratio is 6.87, and the price-to-book ratio stands at 5.46.

As of June 30, 2026, Cica-Huntek Chemical Technology Taiwan Co trades at an EV/EBITDA multiple of 53.57 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 6.66 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 56.70 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 12.55B versus a market cap of 12.96B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Cica-Huntek Chemical Technology Taiwan Co maintains a current ratio of 2.08, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 18.32, indicating elevated leverage, while an interest coverage ratio of 51.83 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Cica-Huntek Chemical Technology Taiwan Co posted a return on equity (ROE) of 7.47, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 6.12 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 4.03, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 6.38, useful for judging operating efficiency across full business cycles. The company generates approximately 5.05M in revenue per employee across its workforce of 373.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.70 indicates how many times Cica-Huntek Chemical Technology Taiwan Co sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Cica-Huntek Chemical Technology Taiwan Co recorded 39.84M in income tax expense. That works out to an effective tax rate of 18.13, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 219.73M, leaving 179.89M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Cica-Huntek Chemical Technology Taiwan Co's stock has declined approximately 28.04% over the past 52 weeks. The 50-day moving average sits at 218.52, while the 200-day moving average is 272.84.

Over the twelve months ended June 30, 2026, Cica-Huntek Chemical Technology Taiwan Co generated 1.88B in revenue and converted that into 179.89M in net income, yielding earnings per share of 4.84. EBITDA reached 234.19M, while operating income came in at 225.83M.

As of June 30, 2026, Cica-Huntek Chemical Technology Taiwan Co holds 847.03M in cash and equivalents against 434.67M in total debt, resulting in a net debt position of -185.34M. Total book value stands at 2.37B, with working capital of 2.10B providing operational flexibility.

Cica-Huntek Chemical Technology Taiwan Co produced -417.78M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -276.95M in capital expenditures, free cash flow totaled -694.74M - equivalent to -18.73 per share.

Over the twelve months ended June 30, 2026, Cica-Huntek Chemical Technology Taiwan Co posted a gross margin of 22.88, reflecting its pricing power and cost economics. The operating margin of 11.99 and net profit margin of 9.55 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -5.36: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 0.68, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Cica-Huntek Chemical Technology Taiwan Co shareholders.

Cica-Huntek Chemical Technology Taiwan Co's most recent stock split took place on December 18, 2019 with a 4:5 split ratio.

As of June 30, 2026, Cica-Huntek Chemical Technology Taiwan Co has an Altman Z-Score of 4.92, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.